Meyka Pro banner
Profusa, Inc. Common Stock

Profusa, Inc. Common Stock Fundamental Analysis (NASDAQ: PFSA)

PFSA●NASDAQ
HealthcareMedical - Devices
$2.21
$0.16(7.80%)
U.S. Market is Open · 11:49

Profusa, Inc. Common Stock Fundamental Analysis (NASDAQ: PFSA)

Profusa, Inc. Common Stock (NASDAQ: PFSA) shows weak financial fundamentals with a PE ratio of -0.01, profit margin of 0.00%, and ROE of 1.48%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position411.43%
PEG Ratio-0.00

Areas of Concern

ROE1.48%
Operating Margin0.00%
Current Ratio0.03
We analyze PFSA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -627.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-627.4/100

We analyze PFSA's fundamental strength across five key dimensions:

Efficiency Score

Weak

PFSA struggles to generate sufficient returns from assets.

ROA > 10%
-41.24%

Valuation Score

Excellent

PFSA trades at attractive valuation levels.

PE < 25
-0.01
PEG Ratio < 2
-0.00

Growth Score

Weak

PFSA faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

PFSA shows balanced financial health with some risks.

Debt/Equity < 1
-0.52
Current Ratio > 1
0.03

Profitability Score

Weak

PFSA struggles to sustain strong margins.

ROE > 15%
148.25%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is PFSA Expensive or Cheap?

P/E Ratio

PFSA trades at -0.01 times earnings. This suggests potential undervaluation.

-0.01

PEG Ratio

When adjusting for growth, PFSA's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Profusa, Inc. Common Stock at -0.01 times its book value. This may indicate undervaluation.

-0.01

EV/EBITDA

Enterprise value stands at 0.29 times EBITDA. This is generally considered low.

0.29

How Well Does PFSA Make Money?

Net Profit Margin

For every $100 in sales, Profusa, Inc. Common Stock keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $1.48 in profit for every $100 of shareholder equity.

1.48%

ROA

Profusa, Inc. Common Stock generates $-41.24 in profit for every $100 in assets, demonstrating efficient asset deployment.

-41.24%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-364.80 in free cash annually.

$-364.80

FCF Yield

PFSA converts -6.34% of its market value into free cash.

-6.34%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.01

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.01

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.52

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.03

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

1.48

vs 25 benchmark

ROA

Return on assets percentage

-41.24

vs 25 benchmark

ROCE

Return on capital employed

1.17

vs 25 benchmark

How PFSA Stacks Against Its Sector Peers

MetricPFSA ValueSector AveragePerformance
P/E Ratio-0.0130.54 Better (Cheaper)
ROE148.25%579.00% Weak
Net Margin0.00%24148.00% Weak
Debt/Equity-0.520.52 Strong (Low Leverage)
Current Ratio0.035.66 Weak Liquidity
ROA-4123.80%-58.00% (disorted) Weak

PFSA outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Profusa, Inc. Common Stock's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ